0.38
price down icon8.61%   -0.0358
pre-market  プレマーケット:  .40   0.02   +5.26%
loading

Curis Inc (CRIS) 最新ニュース

pulisher
Jun 10, 2026

CRIS Q1 2026 Earnings: Deep EPS Miss Highlights Pre-Revenue Challenges Amid Strategic PivotQuarterly Earnings - newsline.com

Jun 10, 2026
pulisher
Jun 09, 2026

Curis stock (US2312691006): Cancer biotech faces Nasdaq compliance deadline after reverse stock spli - AD HOC NEWS

Jun 09, 2026
pulisher
Jun 05, 2026

Q1 2026 Curis Inc Earnings Call Transcript - GuruFocus

Jun 05, 2026
pulisher
Jun 05, 2026

Curis (NASDAQ: CRIS) plans reverse stock split to address Nasdaq bid price - Stock Titan

Jun 05, 2026
pulisher
Jun 01, 2026

CRIS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 01, 2026
pulisher
May 31, 2026

Curis Inc. (CRIS) Surges 8.33%: Momentum Builds Above Key SupportVolatility Stop - newsline.com

May 31, 2026
pulisher
May 29, 2026

CRIS News | CURIS INC (NASDAQ:CRIS) - ChartMill

May 29, 2026
pulisher
May 28, 2026

CRIS Q1 2026 Earnings: Significant EPS Miss Highlights Ongoing Pre-Revenue ChallengesEarnings Deceleration Risk - The Legal Advocate

May 28, 2026
pulisher
May 26, 2026

CRIS Q1 2026 Earnings: Significant EPS Miss as Biotech Advances Pipeline Without RevenueRevenue Per Share - The Legal Advocate

May 26, 2026
pulisher
May 24, 2026

Curis Inc. Q1 2026 Earnings: Deep EPS Miss as Pre-Revenue Biotech Continues DevelopmentShare Dilution Risk - Newser

May 24, 2026
pulisher
May 23, 2026

CRIS Q1 2026 Earnings: Significant EPS Miss Amidst Operational UpdatesEPS Growth Rate - The Legal Advocate

May 23, 2026
pulisher
May 22, 2026

Curis Shareholders Approve Expanded Capital Structure and Governance - TipRanks

May 22, 2026
pulisher
May 22, 2026

Curis (NASDAQ: CRIS) wins shareholder approval to double authorized common stock - Stock Titan

May 22, 2026
pulisher
May 21, 2026

Curis stock (US2312691006): Phase 1 data update lifts attention - AD HOC NEWS

May 21, 2026
pulisher
May 19, 2026

Curis Inc Annual Shareholders Meeting Transcript - GuruFocus

May 19, 2026
pulisher
May 19, 2026

CRIS: All five shareholder proposals, including director elections and share increase, were approved - TradingView

May 19, 2026
pulisher
May 18, 2026

Curis to Host Webcast to Discuss Updated Emavusertib Clinical Da - GuruFocus

May 18, 2026
pulisher
May 18, 2026

Curis Faces Nasdaq Delisting Determination, Plans Appeal Hearing - TipRanks

May 18, 2026
pulisher
May 18, 2026

Why Curis (CRIS) Just Dropped -2.08% — What to Watch 2026-05-18Risk Reversal - The Legal Advocate

May 18, 2026
pulisher
May 16, 2026

Curis stock (US2312691006): cancer pipeline update keeps investors cautious - AD HOC NEWS

May 16, 2026
pulisher
May 15, 2026

Armistice Capital (NASDAQ: CRIS) reports 4.99% ownership of Curis - Stock Titan

May 15, 2026
pulisher
May 14, 2026

JonesTrading Maintains Curis(CRIS.US) With Buy Rating, Maintains Target Price $5 - Moomoo

May 14, 2026
pulisher
May 14, 2026

Thomas Satterfield holds 3.96M shares as Curis (CRIS) ownership amended - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Curis, Inc. (NASDAQ:CRIS) Q1 2026 Earnings Call Transcript - Insider Monkey

May 14, 2026
pulisher
May 13, 2026

Curis Q1 2026 earnings preview - MSN

May 13, 2026
pulisher
May 13, 2026

Curis Inc. Earnings Call Highlights Clinical Momentum - TipRanks

May 13, 2026
pulisher
May 13, 2026

Curis Q1 2026 Deep Dive: EPS Misses by 331.0%, Revenue Down 100% - AlphaStreet

May 13, 2026
pulisher
May 13, 2026

Curis, Inc. (CRIS) Reports Q1 2026 Loss and Updates on Clinical Trials - GuruFocus

May 13, 2026
pulisher
May 13, 2026

CURIS INC 1Q 2026: Revenue $0 Net income ($24.2M), EPS ($1.25) — 10-Q Summary - TradingView

May 13, 2026
pulisher
May 13, 2026

Curis (NASDAQ: CRIS) posts larger Q1 2026 loss and warns on going concern - Stock Titan

May 13, 2026
pulisher
May 13, 2026

Curis, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 13, 2026
pulisher
May 13, 2026

Curis anticipates TakeAim CLL initial 5-patient dosing by mid-2026 while projecting cash runway into second half of '27 - MSN

May 13, 2026
pulisher
May 13, 2026

Curis Inc (CRIS) Q1 2026 Earnings Call Highlights: Progress in L - GuruFocus

May 13, 2026
pulisher
May 12, 2026

Curis (CRIS) Expects Sufficient Funding to Support Operations Un - GuruFocus

May 12, 2026
pulisher
May 12, 2026

Earnings call transcript: Curis Q1 2026 reveals widened net loss - Investing.com UK

May 12, 2026
pulisher
May 12, 2026

Curis (CRIS) Reports Q1 Revenue Below Expectations - GuruFocus

May 12, 2026
pulisher
May 12, 2026

Curis Q1 2026 Earnings Call Transcript - MarketBeat

May 12, 2026
pulisher
May 12, 2026

Curis (CRIS) Q1 Miss: EPS -$1.25 vs -$0.40 est, Revenue $0 vs $1 - GuruFocus

May 12, 2026
pulisher
May 12, 2026

Curis Provides First Quarter 2026 Business Update - GuruFocus

May 12, 2026
pulisher
May 12, 2026

Curis Sees Cash Runway Into the 2H of 2027 >CRIS - Moomoo

May 12, 2026
pulisher
May 12, 2026

Earnings call transcript: Curis Q1 2026 reveals widened net loss By Investing.com - Investing.com Nigeria

May 12, 2026
pulisher
May 12, 2026

Curis Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga

May 12, 2026
pulisher
May 12, 2026

Curis Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2026
pulisher
May 12, 2026

Curis reports Q1 loss, expects CLL trial milestone by mid-2026 - Investing.com South Africa

May 12, 2026
$30.41
price up icon 1.27%
$55.40
price up icon 6.27%
$89.50
price down icon 1.43%
$54.21
price down icon 0.11%
ONC ONC
$263.92
price down icon 1.60%
$156.58
price down icon 2.17%
大文字化:     |  ボリューム (24 時間):